In particular, hyperuricemia inhibited a protein kinase B (AKT) response to insulin by decreasing its phosphorylation and conversely increasing the phosphorylation of the insulin receptor substrate-1 (IRS1) in liver, muscle and fat tissue, thus fostering the onset of IR. The gene discussed is INS; the disease is hyperuricemia.